📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

P153 Rituximab and tocilizumab and their effect on lung disease progression in scleroderma: a retrospective cohort study at a single centre (2023)

First Author: Goldman N

Attributed to: Defining pathogenic B cell regulation and role in scleroderma-associated interstitial lung disease (SSc-ILD) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/kead104.194

Publication URI: http://dx.doi.org/10.1093/rheumatology/kead104.194

Type: Journal Article/Review

Parent Publication: Rheumatology

Issue: Supplement_2